{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:50:47Z","timestamp":1781625047764,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-025-04036-4","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T21:01:07Z","timestamp":1745874067000},"page":"769-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Microwave Ablation of Colorectal Pulmonary Metastases Offers Excellent Local Tumor Control and Can\u00a0Prolong Time Off Chemotherapy"],"prefix":"10.1007","volume":"48","author":[{"given":"Timothy M.","family":"Cooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos T.","family":"Sofocleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etay","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-1369","authenticated-orcid":false,"given":"Vlasios S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"7","key":"4036_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669\u201385.","journal-title":"JAMA"},{"issue":"3","key":"4036_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"4036_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/gut.2010.211557","volume":"59","author":"E Mitry","year":"2010","unstructured":"Mitry E, et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010;59(10):1383\u20138.","journal-title":"Gut"},{"issue":"1","key":"4036_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","journal-title":"Ann Oncol"},{"key":"4036_CR5","unstructured":"National Comprehensive Cancer Network (NCCN) Guidelines - Colon Cancer (Version 5.2024). Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf. Accessed 20 Nov 2024."},{"issue":"2","key":"4036_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","volume":"20","author":"M Gonzalez","year":"2013","unstructured":"Gonzalez M, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4036_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1258\/jrsm.2009.090299","volume":"103","author":"F Fiorentino","year":"2010","unstructured":"Fiorentino F, et al. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med. 2010;103(2):60\u20136.","journal-title":"J R Soc Med"},{"issue":"11","key":"4036_CR8","first-page":"e489","volume":"107","author":"T Treasure","year":"2020","unstructured":"Treasure T, et al. Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial. Br J Surg. 2020;107(11):e489\u201390.","journal-title":"Br J Surg"},{"issue":"7","key":"4036_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/cancers16071408","volume":"16","author":"F Petrella","year":"2024","unstructured":"Petrella F, et al. Colorectal Cancer Pulmonary Metastasectomy: When, Why and How. Cancers (Basel). 2024;16(7):689.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4036_CR10","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.21037\/jtd-2019-pm-14","volume":"13","author":"P Beckers","year":"2021","unstructured":"Beckers P, et al. Pulmonary metastasectomy in colorectal carcinoma. J Thorac Dis. 2021;13(4):2628\u201335.","journal-title":"J Thorac Dis"},{"issue":"1","key":"4036_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.athoracsur.2007.02.093","volume":"84","author":"J Pfannschmidt","year":"2007","unstructured":"Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324\u201338.","journal-title":"Ann Thorac Surg"},{"key":"4036_CR12","doi-asserted-by":"crossref","unstructured":"Embun R, et al. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open. 2013;3(5).","DOI":"10.1136\/bmjopen-2013-002787"},{"issue":"1","key":"4036_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.surg.2006.07.020","volume":"141","author":"H Kobayashi","year":"2007","unstructured":"Kobayashi H, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67\u201375.","journal-title":"Surgery"},{"issue":"4","key":"4036_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2214\/AJR.17.18368","volume":"209","author":"SK Mouli","year":"2017","unstructured":"Mouli SK, Kurilova I, Sofocleous CT, Lewandowski RJ. The role of percutaneous image-guided thermal ablation for the treatment of pulmonary malignancies. AJR Am J Roentgenol. 2017;209(4):740\u201351.","journal-title":"AJR Am J Roentgenol"},{"key":"4036_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejca.2017.01.010","volume":"75","author":"T de Baere","year":"2017","unstructured":"de Baere T, et al. The role of image-guided therapy in the management of colorectal cancer metastatic disease. Eur J Cancer. 2017;75:231\u201342.","journal-title":"Eur J Cancer"},{"issue":"1","key":"4036_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clcc.2012.07.003","volume":"12","author":"EN Petre","year":"2013","unstructured":"Petre EN, et al. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer. 2013;12(1):37\u201344.","journal-title":"Clin Colorectal Cancer"},{"issue":"10","key":"4036_CR17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s00270-018-2000-6","volume":"41","author":"I Kurilova","year":"2018","unstructured":"Kurilova I, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530\u201344.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"4036_CR18","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/cncr.24952","volume":"116","author":"TC Chua","year":"2010","unstructured":"Chua TC, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer. 2010;116(9):2106\u201314.","journal-title":"Cancer"},{"issue":"3","key":"4036_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/PPO.0000000000000195","volume":"22","author":"PG Kasi","year":"2016","unstructured":"Kasi PG. Chemotherapy maintenance. Cancer J. 2016;22(3):199\u2013204.","journal-title":"Cancer J"},{"issue":"11","key":"4036_CR20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00270-018-1939-7","volume":"41","author":"M Fonck","year":"2018","unstructured":"Fonck M, et al. Pulmonary thermal ablation enables long chemotherapy-free survival in metastatic colorectal cancer patients. Cardiovasc Intervent Radiol. 2018;41(11):1727\u201334.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"4036_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2214\/AJR.15.15895","volume":"207","author":"DM Panicek","year":"2016","unstructured":"Panicek DM, Hricak H. How sure are you, doctor? a standardized lexicon to describe the radiologist\u2019s level of certainty. AJR Am J Roentgenol. 2016;207(1):2\u20133.","journal-title":"AJR Am J Roentgenol"},{"issue":"19","key":"4036_CR22","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1002\/cncr.29507","volume":"121","author":"DE Dupuy","year":"2015","unstructured":"Dupuy DE, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer. 2015;121(19):3491\u20138.","journal-title":"Cancer"},{"key":"4036_CR23","doi-asserted-by":"publisher","first-page":"153303382210944","DOI":"10.1177\/15330338221094429","volume":"21","author":"W Wu","year":"2022","unstructured":"Wu W, et al. Factors associated with pulmonary function changes in patients undergoing microwave ablation for pulmonary ground-glass nodules. Technol Cancer Res Treat. 2022;21:15330338221094428.","journal-title":"Technol Cancer Res Treat"},{"issue":"8","key":"4036_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jvir.2022.04.019","volume":"33","author":"X Wu","year":"2022","unstructured":"Wu X, et al. Microwave ablation versus stereotactic body radiotherapy for stage I non-small cell lung cancer: a cost-effectiveness analysis. J Vasc Interv Radiol. 2022;33(8):964\u201371.","journal-title":"J Vasc Interv Radiol"},{"issue":"25","key":"4036_CR25","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38(25):2830\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4036_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1067\/j.cpradiol.2007.10.001","volume":"38","author":"CL Brace","year":"2009","unstructured":"Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135\u201343.","journal-title":"Curr Probl Diagn Radiol"},{"issue":"1","key":"4036_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/02656736.2021.1936214","volume":"38","author":"F Xu","year":"2021","unstructured":"Xu F, et al. Clinical efficacy of systemic chemotherapy combined with radiofrequency ablation and microwave ablation for lung cancer: a comparative study. Int J Hyperthermia. 2021;38(1):900\u20136.","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"4036_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/bjs.4392","volume":"91","author":"J King","year":"2004","unstructured":"King J, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg. 2004;91(2):217\u201323.","journal-title":"Br J Surg"},{"issue":"4","key":"4036_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3892\/or_00000513","volume":"22","author":"K Yamakado","year":"2009","unstructured":"Yamakado K, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep. 2009;22(4):885\u201391.","journal-title":"Oncol Rep"},{"issue":"5","key":"4036_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Baere","year":"2015","unstructured":"de Baere T, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987\u201391.","journal-title":"Ann Oncol"},{"issue":"3","key":"4036_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jvir.2014.11.013","volume":"26","author":"Y Matsui","year":"2015","unstructured":"Matsui Y, et al. Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases. J Vasc Interv Radiol. 2015;26(3):303\u201310.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"4036_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1148\/radiol.2020191272","volume":"294","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa T, et al. Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: a prospective multicenter study. Radiology. 2020;294(3):686\u201395.","journal-title":"Radiology"},{"key":"4036_CR33","doi-asserted-by":"publisher","first-page":"943715","DOI":"10.3389\/fonc.2022.943715","volume":"12","author":"Y Han","year":"2022","unstructured":"Han Y, et al. Long-term outcome following microwave ablation of lung metastases from colorectal cancer. Front Oncol. 2022;12:943715.","journal-title":"Front Oncol"},{"issue":"10","key":"4036_CR34","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/annonc\/mdq098","volume":"21","author":"TC Chua","year":"2010","unstructured":"Chua TC, et al. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol. 2010;21(10):2017\u201322.","journal-title":"Ann Oncol"},{"issue":"5","key":"4036_CR35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejso.2015.01.024","volume":"41","author":"J Ferguson","year":"2015","unstructured":"Ferguson J, et al. Long term results of RFA to lung metastases from colorectal cancer in 157 patients. Eur J Surg Oncol. 2015;41(5):690\u20135.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"4036_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.6004\/jnccn.2023.7050","volume":"21","author":"L Bakkerus","year":"2023","unstructured":"Bakkerus L, et al. Health-related quality of life in patients with metastatic colorectal cancer undergoing systemic therapy with or without maximal tumor Debulking. J Natl Compr Canc Netw. 2023;21(10):1059\u201366.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04036-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:16:12Z","timestamp":1750083372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04036-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4036"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04036-4","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.T.S. is a paid consultant for Ethicon, Medtronic, Terumo, Boston Scientific\/BTG, SIRTEX Medical Inc and Varian. He has received grants or contracts from the National Institutes of Health, Society of Interventional Oncology, Society of Interventional Radiology Foundation, Varian, Ethicon J&J, Boston Scientific\/BTG, SIRTEX Medical Inc. E.S.A. is a paid consultant for Boston Scientific. E.Z. receives grant support from Ethicon, AACR-NETF, Memorial Sloan Kettering Cancer Center, Society of Interventional Radiology, Radiographic Society of North America, North American Neuroendocrine Tumor Society, Ethicon, Novartis and TOW Center. S.B.S. is a paid consultant for GE Healthcare, Merck and Obsidian; receives grants or contracts from Ethicon, GE Healthcare and Johnson & Johnson; and reports participation in data safety monitoring board of Candel Therapeutics and Impact Biotech, stock or stock options in Johnson & Johnson. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board (IRB) waiver of approval was obtained for this retrospective cohort study (MSKCC: 16-402).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Institutional review board (IRB) waiver of approval was obtained for this retrospective cohort study (MSKCC: 16-402).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}